The Company

Our Story 

PneumRx® is focused on developing minimally-invasive solutions for unmet medical needs in pulmonary medicine.

PneumRx® was founded in 2004 as a venture-backed medical device company in Silicon Valley, and it was acquired by BTG in 2015.  The company is part of BTG’s Interventional Pulmonology business unit and is dedicated to supporting clinicians in improving the lives of patients who suffer from severe emphysema.

PneumRx® has conducted several randomized controlled trials (RCT) of the PneumRx® Coil System, including the completion of a pivotal trial with results published in JAMA in 2016.